Cargando…

Teprotumumab in thyroid eye disease: wonder drug or great divider?

Progress in the management of thyroid eye disease (TED) has been slow for many decades. The recent introduction of teprotumumab (TEP) in the therapeutic arena for TED has had a major impact in view of its efficacy, particularly with respect to its ability to reduce proptosis. However, the high cost...

Descripción completa

Detalles Bibliográficos
Autores principales: Perros, Petros, Hegedüs, Laszlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305462/
https://www.ncbi.nlm.nih.gov/pubmed/37043369
http://dx.doi.org/10.1530/ETJ-23-0043